TG Therapeutics
Kelly Eldridge is an experienced pharmaceutical sales professional with extensive expertise in neurology and rare diseases. Currently serving as Associate Director of Key Accounts at TG Therapeutics, Inc. since May 2024, Eldridge previously held the position of Regional Account Manager for Neurology at Alexion Pharmaceuticals, Inc. from September 2021 to May 2024. Prior roles include Senior Executive Neurology Sales Specialist at Teva Pharmaceuticals, where multiple awards were received for excellence in sales relating to neurological conditions such as Multiple Sclerosis, Huntington's Disease, Tardive Dyskinesia, and Parkinson's Disease, and Professional Sales Representative in the Alzheimer’s division at Pfizer. Eldridge holds a Bachelor's degree from Oklahoma State University and completed high school education at Putnam City High School.
This person is not in any teams
This person is not in any offices
TG Therapeutics
2 followers
TG Therapeutics is a fully-integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.